FDA Approved: BARHEMSYS — Supplemental Application (Acacia Pharma Ltd)

View source ↗

Summary

FDA approved a supplemental application for BARHEMSYS (amisulpride) submitted by Acacia Pharma Ltd, typically reflecting labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Barhemsys (rolapitant)

Snippet

SUPPL AP for BARHEMSYS (AMISULPRIDE)